- Home
- CMCL vs RAPT Comparison
CMCL vs RAPT Comparison
Compare CMCL & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- RAPT
- Stock Information
- Founded
- CMCL 1992
- RAPT 2015
- Country
- CMCL Jersey
- RAPT United States
- Employees
- CMCL N/A
- RAPT N/A
- Industry
- CMCL Precious Metals
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- CMCL Basic Materials
- RAPT Health Care
- Exchange
- CMCL Nasdaq
- RAPT Nasdaq
- Market Cap
- CMCL 544.4M
- RAPT 498.4M
- IPO Year
- CMCL N/A
- RAPT 2019
- Fundamental
- Price
- CMCL $30.58
- RAPT $33.50
- Analyst Decision
- CMCL Strong Buy
- RAPT Strong Buy
- Analyst Count
- CMCL 1
- RAPT 9
- Target Price
- CMCL $28.00
- RAPT $57.00
- AVG Volume (30 Days)
- CMCL 249.8K
- RAPT 401.0K
- Earning Date
- CMCL 11-10-2025
- RAPT 11-06-2025
- Dividend Yield
- CMCL 1.83%
- RAPT N/A
- EPS Growth
- CMCL 908.66
- RAPT N/A
- EPS
- CMCL 2.58
- RAPT N/A
- Revenue
- CMCL $228,245,000.00
- RAPT N/A
- Revenue This Year
- CMCL $47.83
- RAPT N/A
- Revenue Next Year
- CMCL $3.20
- RAPT N/A
- P/E Ratio
- CMCL $11.20
- RAPT N/A
- Revenue Growth
- CMCL 38.04
- RAPT N/A
- 52 Week Low
- CMCL $8.81
- RAPT $5.67
- 52 Week High
- CMCL $38.75
- RAPT $42.39
- Technical
- Relative Strength Index (RSI)
- CMCL 55.76
- RAPT 68.63
- Support Level
- CMCL $26.56
- RAPT $26.50
- Resistance Level
- CMCL $29.69
- RAPT $29.29
- Average True Range (ATR)
- CMCL 1.49
- RAPT 1.77
- MACD
- CMCL 0.36
- RAPT 0.12
- Stochastic Oscillator
- CMCL 98.91
- RAPT 83.60
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.